A Guide from Dr. Starsiak · Lupus, RA, Psoriasis, Colitis, Crohn's, Hashimoto's

Autoimmune disease:
what you can add

Diet, movement, sleep, the handful of supplements with real trial data, and one old generic drug worth knowing about. Ranked by evidence, matched to the diagnosis, and meant to sit beside your prescribed treatment.

About the links on this page: where I name a product, the dispensary link comes first when it stocks a professional-grade version, and Amazon covers the rest. Both support the clinic at no extra cost to you, and as an Amazon Associate I earn from qualifying purchases. Buy anywhere you like; check third-party testing and match the studied dose.

What has real evidence,
in one screen

If you live with lupus, rheumatoid arthritis, psoriasis, Crohn's, ulcerative colitis or Hashimoto's, you have probably been handed two opposite stories: that nothing but prescriptions matters, or that the right diet and a bag of supplements will cure you. Neither holds up. I went through the trials for diet, fasting, exercise, sleep, plant medicines from several traditions and non-patented physician therapies, and ranked what I found.

The honest summary: food and movement did as well as the best supplements in the trials, a handful of supplements have real data for specific diagnoses, several popular ones failed, and a few herbs are worth avoiding. Everything here is meant to sit beside your prescribed treatment. None of these trials tested stopping it.

The supplements, up front
  • Omega-3 at 2.7 g or more a day, for rheumatoid arthritis. A consistent but modest drop in pain, morning stiffness and NSAID use. It failed in Crohn's. → details
  • Curcumin added to mesalamine, for ulcerative colitis. About five times the odds of remission across six trials. It carries a real liver caution. → details
  • The original 8-strain probiotic, for ulcerative colitis. Remission in 44% against 25% on placebo. → details
  • N-acetylcysteine, for lupus. One small placebo-controlled trial showed less disease activity and fatigue. → details
  • Vitamin D. Worth correcting when low. Its prevention signal faded on longer follow-up. → details
  • Selenium, for Hashimoto's. Lowers antibodies; not yet shown to change the course of the disease. → details
  • Sirolimus. A generic prescription drug made by a soil bacterium, with encouraging early data in lupus and RA. Physician-guided only. → details
Jump to the supplements →Find your condition

Four ground rules, and
how to read the labels

Ground rules
  • Keep your prescribed treatment. Every trial on this page added something to standard care. None tested stopping a disease-modifying drug, and uncontrolled disease does permanent damage to joints, kidneys and bowel.
  • Tell your prescriber what you add. Several of these interact with immunosuppressants, blood thinners or liver-stressing drugs. The specific ones are named where they come up.
  • Doses are the ones the trials used, not a personal prescription. Almost none of these trials enrolled children or pregnant or breastfeeding women, so the doses do not apply to them without a physician.
  • Feeling better is not the same as being controlled. Inflammation can continue quietly. The measures to follow for each condition are listed near the end.
How to read the evidence labels
  • Established — clinically meaningful, reasonably consistent benefit in good-quality trials.
  • Promising — controlled trials show a clinical benefit, with limits such as small size or no replication.
  • Preliminary — an early signal: small or uncontrolled studies, or benefit shown mainly on lab markers. I include these only when they are safe and inexpensive.
  • Not effective — adequately sized trials found no benefit.

A thin evidence base usually reflects funding, not merit: an unpatentable plant is rarely beaten in a trial, it is simply never entered into one. So an item with a good early signal stays on this page when it is safe and cheap, and an item that works is left off when it is dangerous. I did not drop anything because a guideline omits it; where a guideline and the trial data disagree, I report both.

One note on scope. Psoriasis, Crohn's disease, ulcerative colitis and ankylosing spondylitis are immune-mediated inflammatory diseases, not classical antibody-driven autoimmune diseases like lupus or Hashimoto's. I group them here because patients do, but a finding in one does not transfer to another. That is the main reason there is no single “autoimmune stack” on this page.

Call your physician now, not after trying something here
  • New chest pain, shortness of breath, or coughing blood
  • Fever while you are on an immunosuppressant or a biologic
  • Bloody diarrhea with fever, severe belly pain, or signs of dehydration
  • Foamy urine, new leg swelling, or a sudden rise in blood pressure with lupus
  • Sudden vision change, new weakness or numbness, or loss of bladder or bowel control
  • A hot, swollen joint with fever

Where the evidence is
for your diagnosis

Start with your row, then read the sections it points to. The order within each row is by strength of evidence.

Condition Best-supported additions Read more
Rheumatoid arthritis Exercise. A plant-forward or Mediterranean diet. Omega-3 at 2.7 g or more. Curcumin, with less certainty. RA →
Lupus Sun protection and not smoking. Seven or more hours of sleep. Omega-3. N-acetylcysteine. Vitamin D when low. Lupus →
Psoriasis and psoriatic arthritis Weight loss when overweight. A Mediterranean diet. Topical indigo naturalis. Meditation. Curcumin, with less certainty. Psoriasis →
Ulcerative colitis Curcumin added to mesalamine. The original 8-strain probiotic. Psyllium as a fiber adjunct. Ulcerative colitis →
Crohn's disease An exclusion diet with a dietitian. Not smoking. Correcting B12, iron and vitamin D. Time-restricted eating for symptoms and weight. Crohn's →
Hashimoto's thyroiditis Selenium as a time-limited trial. Avoiding kelp and high-dose iodine. Hashimoto's →
Multiple sclerosis, very early High-dose vitamin D, physician-directed. MS →
Sjogren's; scleroderma and Raynaud's Mostly symptom care. Very little has been replicated, and I'd rather say so than pad the list. Sjogren's and scleroderma →
Ankylosing spondylitis Exercise, which has its strongest evidence here. Foundations →

Food, weight, movement
and sleep

If you came for the supplement list, it is just below. I put this section first because in the randomized trials, diet pattern, body weight and meal timing produced effects as large as the best-studied supplements, and they cost less.

What Evidence What the trials showed Cautions
Mediterranean diet, dietitian-guided Promising Psoriasis: 16 weeks cut the PASI score by 3.4 points against no change on low-fat advice, and 47% reached a 75% improvement against none of the controls, in a small open-label trial of 38 patients (MEDIPSO). RA: people with the highest adherence had a 29% lower risk of developing it (UK Biobank). None of note.
Whole-food plant-based diet with exercise and stress management Promising RA with low-to-moderate activity: the DAS28 score improved 0.9 points more than usual care at 16 weeks in 83 patients (Plants for Joints), and the benefit held at 2 years. The three changes were made together, so the credit cannot go to diet alone. Take B12 on a fully plant-based diet.
Weight loss, when overweight Established Psoriasis: the only dietary measure the National Psoriasis Foundation's medical board strongly recommends; weakly recommended in psoriatic arthritis. Applies to overweight and obese patients.
Crohn's disease exclusion diet, or exclusive enteral nutrition Established in children; Promising in adults Children: an exclusion diet with partial enteral nutrition gave 80% remission against 75% on exclusive enteral nutrition. Adults: effective in a pilot trial and tested against the Mediterranean diet in a 2025 trial. Needs a dietitian. Malnutrition is a real risk if done alone.
Time-restricted eating, 16:8 Promising for symptoms, not inflammation Crohn's in remission with overweight: 12 weeks improved the symptom index, BMI and visceral fat without calorie counting in 35 patients (trial announcement). CRP and fecal calprotectin did not change. Not tested in active or underweight Crohn's.
Fasting 7 to 10 days, then a vegetarian diet Promising, supervised only RA: 27 patients who fasted and then ate vegetarian improved on every clinical measure against 26 controls over 13 months, and four controlled studies pooled show lasting benefit (systematic review). The gains fade when the old diet resumes (umbrella review). Medically supervised only. Not for anyone underweight, pregnant, on insulin or a sulfonylurea, with an eating-disorder history, or on steroids without physician input. These trials predate modern RA drugs.
5:2 modified fasting Preliminary Psoriasis pilot of 24 patients: less scaling, thickness and itch by patient report; the PASI score did not differ significantly (MANGO). Same exclusions as fasting.
Very-low-calorie ketogenic diet, 8 to 9 weeks Preliminary Psoriasis and psoriatic arthritis with overweight: skin and joint scores and IL-17 and IL-23 fell after the ketogenic phase but not the Mediterranean phase of a small crossover trial (report). Weight loss confounds the result. Short term only. Avoid in pregnancy, type 1 diabetes, SGLT2-inhibitor use, or a history of pancreatitis.
Gluten-free diet Established in celiac disease; Preliminary in psoriasis Psoriasis: weakly recommended only for patients with positive gluten-antibody blood tests (NPF board). No support for universal use.
Exercise, aerobic plus resistance Established Safe and beneficial for pain and disability across rheumatic disease, and strongest in ankylosing spondylitis (EULAR 2021). It is the single strong recommendation in the American College of Rheumatology's integrative guideline for RA. Scale it to flares.
Sleep, 7 hours or more Preliminary (observational) Sleeping 5 hours or less carried 2.47 times the risk of developing lupus compared with 7 to 8 hours, in 186,072 women (Nurses’ Health Studies). No trial yet shows that extending sleep lowers disease activity. None.
Meditation and guided imagery Promising Psoriasis: modest benefit in three single-blind trials, 112 patients (JAMA Dermatology review). None.
Not smoking; limiting alcohol Established (guideline) Smokers should be supported to quit; small amounts of alcohol are unlikely to worsen outcomes, though RA may flare with moderate intake (EULAR 2021). None.

If you want a starting point for the movement and sleep pieces, I have written them out step by step: getting started with strength training, sleep that actually restores you, and for the bowel conditions, improving gut health from the root.

Match the supplement
to the diagnosis

Vitamin D, omega-3, curcumin and specific probiotics account for most of the positive randomized data. Each helps some conditions and clearly fails in others. This is a labeled shelf, not a protocol: nobody needs everything on it, and most people need one or two items at most.

Where to get these. Each item links to my dispensary when it carries a suitable product (free account, practitioner-grade brands) and to Amazon. Buy anywhere you like; check for third-party testing and match the form and dose that was studied. Disclosure: as an Amazon Associate, Starsiak Osteopathic Clinic earns from qualifying purchases through the Amazon links, and I earn from purchases through the dispensary, at no extra cost to you. The advice is the same wherever you buy.

Omega-3 (EPA + DHA) (Promising for RA symptoms)
  • Where it works. RA: less joint pain, shorter morning stiffness, fewer tender joints and lower NSAID use after 3 to 4 months (meta-analysis of 17 trials; 30-trial update). Lupus: lower inflammatory markers and disease activity in small trials (review).
  • Where it does not. Crohn's maintenance: 4 g a day was no better than placebo in 738 patients (EPIC trials). Psoriasis skin: most of 12 trials were negative (review). No trial shows it slows joint erosions in RA.
  • Prevention is a separate finding. In the VITAL trial follow-up, 1 g a day gave 17% fewer new autoimmune diagnoses at 7 years (Arthritis Rheumatol 2024). That says nothing about treating established disease.
  • Dose studied. 2.7 g or more of EPA plus DHA daily for at least 3 months in RA. Read the label for EPA plus DHA, not total fish oil.
  • Where the guideline disagrees. The American College of Rheumatology conditionally recommends against adding supplements, fish oil included, for RA outcomes (summary). The trial results are real; the panel judged the benefit too small or uncertain to endorse. You are weighing a modest symptomatic benefit against a low-risk supplement.
  • Cautions. Bleeding risk with anticoagulants. In cardiology trials, doses above 1 g a day were linked to more atrial fibrillation (Circulation 2021), so raise it with your physician if you have a rhythm history.
  • Where to get it (dispensary · Amazon). The trials used fish oil. My apothecary is vegetarian, so both links are algae-derived EPA and DHA, the same molecules from the organism the fish get them from. The honest trade-off is capsule count: the dispensary product gives 500 mg of EPA plus DHA per capsule, so the RA dose is five to six capsules a day; the Amazon product gives 585 mg per two softgels. A concentrated, third-party-tested fish oil reaches 2.7 g in fewer capsules if you prefer it.
Curcumin (Promising in ulcerative colitis; less certain elsewhere)
  • Ulcerative colitis. Added to mesalamine, the pooled odds of clinical remission were 5.18 times higher and of endoscopic remission 5.69 times higher across six trials of 349 patients (meta-analysis). In the 89-patient maintenance trial the dose was 1 g twice daily for 6 months (review).
  • Rheumatoid arthritis. DAS28 fell about 1.2 points across six publications of 539 patients, most at high risk of bias (meta-analysis). Promising, low certainty.
  • Psoriasis. Significant plaque improvement in three trials of 118 patients (review). Preliminary; the trial formulations are not the ones on retail shelves.
  • Lupus. No added effect on top of vitamin D in one trial (review).
  • The liver caution is real. The U.S. liver-injury registry adjudicated ten cases linked to turmeric: five hospitalized, one death, onset at 1 to 4 months, strongly tied to a specific gene variant (HLA-B*35:01) and often to black-pepper-enhanced products (DILIN series). That is rare against the number of people taking it, and it is why I treat curcumin in these doses as clinician-guided.
  • How I'd handle it. Choose a product without black pepper extract (piperine); that is a precaution, not proof of safety. Stop at dark urine, yellow eyes or skin, or new itching. Check liver enzymes at baseline and at 8 weeks. Take extra care with liver disease or alongside methotrexate, leflunomide or azathioprine. Also ask first with gallstones or blood thinners.
  • Where to get it (dispensary · Amazon). The dispensary product is a plain 95%-curcuminoid extract at 400 mg per capsule with no piperine, so the colitis maintenance dose is five capsules a day. The enhanced-absorption curcumin I use for joint pain is a different preparation with its own trials, and it was not what these studies used.
The original 8-strain probiotic (Promising in ulcerative colitis)
  • Ulcerative colitis. Remission in 43.8% against 24.8% on placebo, on top of conventional therapy (meta-analysis). That is 19 points absolute, or about one extra remission for every five to six people treated.
  • The exact product matters. The trials used the De Simone formulation, sold as VSL#3 until 2016 and now sold in the United States as Visbiome. A federal court found that today's VSL#3 is a materially different blend (ruling summary).
  • What the guideline says. The American Gastroenterological Association makes no recommendation on probiotics in ulcerative colitis, citing a knowledge gap. A second probiotic, E. coli Nissle 1917, matched mesalazine for maintenance in pooled trials (meta-analysis).
  • Where it does not work. Crohn's disease: no effect on inducing or maintaining remission (meta-analysis).
  • Dose studied. 3.6 trillion CFU a day. Check the count per sachet or capsule before you buy; cost is the main barrier at this dose.
  • Cautions. Ask first if you have a central line or are heavily immunosuppressed.
  • Where to get it (Amazon). My dispensary does not carry this formulation, and I would not substitute a different probiotic for it, so this is an Amazon link only.
N-acetylcysteine (NAC) (Promising in lupus, single small trial)
  • Lupus. 2.4 to 4.8 g a day reduced disease activity and fatigue in a placebo-controlled trial of 36 patients (review). It acted on the same mTOR pathway in T cells that sirolimus blocks, which makes it the non-prescription route to that target.
  • Other conditions. Not tested at trial level.
  • Dose studied. 2.4 g a day was the lower effective dose. Nausea and stomach upset rise at 4.8 g.
  • Where to get it (dispensary · Amazon). At 600 mg per capsule the trial dose is four capsules a day. Read the label: some NAC products add selenium, which adds up at this capsule count. Tell your rheumatologist you are taking it.
Vitamin D3 (Preliminary for disease outcomes)
  • Prevention, now uncertain. The first VITAL report found 22% fewer new autoimmune diagnoses over 5.3 years in 25,871 adults taking 2,000 IU a day (BMJ 2022). After more cases were confirmed, and two years after the pills stopped, the difference was gone (Arthritis Rheumatol 2024). The authors read that as a benefit that needs continuous supplementation. I read it as no longer a secure finding.
  • Where there is a signal. Very early MS, at high dose under a physician (below). Crohn's: relapse in 13% against 29% over a year on 1,200 IU daily, which narrowly missed statistical significance (trial). Psoriatic arthritis: a weak recommendation from the psoriasis foundation's board.
  • Where it does not help. Lupus: better lab markers but usually unchanged activity scores (review). Hashimoto's antibodies: no reduction at 6 months (meta-analysis). Psoriasis skin: not recommended by the foundation's board.
  • What I'd do. Measure a 25-OH vitamin D level and correct it if it is low. People who avoid the sun because of lupus are often deficient. 2,000 IU a day is the dose VITAL and the lupus trial used.
  • Cautions. Check calcium along with the level. Avoid unsupervised high doses with sarcoidosis, hyperparathyroidism or a history of kidney stones.
  • Where to get it (dispensary · Amazon). Both are vegan D3 from lichen.
Selenium (Preliminary: lab markers only)
  • Hashimoto's. Across 35 trials it lowered TPO antibodies, and slightly lowered TSH in patients not yet on levothyroxine (Thyroid 2024). No trial shows it prevents hypothyroidism, reduces the need for levothyroxine, or improves symptoms.
  • Dose studied. 80 to 400 mcg a day for 2 to 12 months.
  • The margin is narrow. The U.S. upper limit is 400 mcg a day from all sources (NIH) and the European limit is 255 mcg (EFSA 2023). A 200 mcg capsule plus an ordinary diet already exceeds the European figure. Count multivitamins and Brazil nuts. Chronic excess causes hair and nail loss.
  • What I'd do. Treat it as a time-limited trial with a repeat TSH and TPO antibody level, not a permanent supplement. It is not an immune supplement for other conditions.
  • Where to get it (dispensary · Amazon). The dispensary capsule is 200 mcg; the Amazon link searches for 100 mcg capsules, which leave more room under the limits.
Psyllium (Preliminary, as a fiber adjunct in ulcerative colitis)
  • Ulcerative colitis in remission. In an open-label trial of 105 patients over 6 months, relapse occurred in 40% on Plantago ovata seeds, 35% on mesalazine and 30% on both, with no significant difference (review). No difference in an open trial is not proof of equivalence.
  • How to use it. As an addition. Never as a substitute for mesalamine.
  • Dose studied. 10 g twice daily, with plenty of water.
  • Cautions. Not with known strictures. Take it apart from medications.
  • Where to get it (dispensary · Amazon). The trial used the seeds; retail psyllium husk is the closest equivalent.
The early-signal shelf (Preliminary)
  • Boswellia, ulcerative colitis. In a 30-patient study, 14 of 20 on Boswellia gum resin (900 mg a day in three doses for 6 weeks) reached remission against 4 of 10 on sulfasalazine (review). That is too small to claim equivalence, and a placebo-controlled maintenance trial in Crohn's (82 patients) was negative. (dispensary · Amazon; both are standardized extracts, not the raw resin studied.)
  • Mastic gum, Crohn's disease. A pilot of 10 patients taking 2.2 g a day for 4 weeks showed a lower activity index and lower IL-6 and CRP (review). Well tolerated. (dispensary · Amazon)
  • Aloe vera inner-leaf gel, ulcerative colitis. 100 mL twice daily for 4 weeks produced more clinical responses than placebo in 44 patients (review). Use decolorized inner-leaf gel only; whole-leaf latex is a stimulant laxative. No link, because I cannot vouch for a specific product.
  • Wheatgrass juice, ulcerative colitis. 100 mL a day for a month reduced disease activity and rectal bleeding against placebo in 23 patients (review). Nausea was the only side effect reported.
  • Andrographis, ulcerative colitis. A proprietary extract at 1,800 mg a day gave a clinical response in 60% against 40% on placebo in 224 patients; remission at 8 weeks did not differ (review). Retail andrographis is not that extract, so I don't link one. Avoid in pregnancy.
  • Topical indigo naturalis, psoriasis. Significant improvement against placebo in five trials of 215 patients (review), which I'd call Promising. It stains skin and fabric blue. The trials used specific ointment preparations, so I don't link a retail product. Topical only: the oral form is on the avoid list.
Tested and not worth buying for this purpose (Not effective)
  • Omega-3 for Crohn's maintenance, and for the skin in psoriasis.
  • Probiotics for Crohn's disease.
  • Myo-inositol or vitamin D to lower Hashimoto's antibodies (meta-analysis).
  • Omega-3 or evening primrose oil to prevent relapse in ulcerative colitis.
  • Boswellia for maintaining remission in Crohn's.

Your diagnosis,
in order

Each list is ranked by strength of evidence, with the measure that tells you whether a change is working.

Rheumatoid arthritis
  • Exercise (Established) for pain and function.
  • A plant-forward or Mediterranean diet (Promising): 0.9 points on the DAS28 in the Plants for Joints trial, alongside exercise and stress management.
  • Omega-3 at 2.7 g or more of EPA plus DHA for at least 3 months (Promising, modest).
  • Supervised fasting, then a vegetarian diet (Promising, physician-supervised).
  • Curcumin (Promising, low certainty), with the liver precautions.
  • Vitamin D when low (Preliminary).
  • Sirolimus, physician-guided.

Measure: joint examination, a DAS28 or CDAI score, function, and X-ray progression where appropriate.

Lupus
  • Sun protection and not smoking (standard care, and the core of managing skin lupus).
  • Sleep of 7 hours or more (Preliminary; short sleep predicts onset).
  • Omega-3 (Promising, low certainty). Many lupus patients with antiphospholipid antibodies are on blood thinners, so ask first.
  • N-acetylcysteine, 2.4 g a day (Promising, single small trial).
  • Vitamin D when low (Preliminary: lab markers improve, activity scores usually don't).
  • A low-glycemic or calorie-restricted diet (Preliminary): both reduced fatigue in a 6-week study of 23 women (review).
  • DHEA and sirolimus, physician-guided.
  • Avoid alfalfa, spirulina, chlorella and echinacea (why).

None of these replaces hydroxychloroquine. Skin-only and discoid lupus have almost no supplement trials of their own, so the systemic data and sun protection carry over. Measure: an activity score, urinalysis and urine protein, kidney function, complement and anti-dsDNA where relevant.

Psoriasis and psoriatic arthritis
  • Weight loss when overweight (Established).
  • A Mediterranean diet (Promising): 47% reached a 75% improvement at 16 weeks against none.
  • Topical indigo naturalis (Promising; see the early-signal shelf).
  • Meditation or guided imagery (Promising, modest), including during phototherapy.
  • Curcumin (Preliminary).
  • A gluten-free diet only with positive gluten-antibody blood tests (Preliminary).
  • Vitamin D by mouth has a weak recommendation in psoriatic arthritis and is not recommended for skin psoriasis.
  • Fish oil does not clear skin (Not effective), though it is reasonable for the cardiovascular risk that psoriasis raises (review).

Measure: the PASI score, body surface area, and quality of life.

Ulcerative colitis

Ulcerative colitis responds to more plant and microbial agents than any other condition here. Measure: symptoms plus fecal calprotectin and CRP, and endoscopy when indicated.

Crohn's disease
  • An exclusion diet or exclusive enteral nutrition, with a dietitian (Established in children, Promising in adults). Diet is the proven non-drug treatment for Crohn's.
  • Not smoking. Smoking worsens the course of Crohn's.
  • Correcting B12, iron and vitamin D by lab values, especially after ileal disease or surgery.
  • Time-restricted eating for symptoms and weight in remission (Promising for symptoms; it did not change inflammatory markers).
  • Vitamin D, 1,200 IU daily (Preliminary).
  • Mastic gum (Preliminary; early-signal shelf) and wormwood, physician-guided.
  • Skip fish oil and probiotics for Crohn's: both failed in adequately sized trials.

Measure: symptoms plus fecal calprotectin and CRP, and endoscopy when indicated.

Hashimoto's thyroiditis
  • Selenium as a time-limited trial with repeat labs (Preliminary).
  • Avoid kelp and high-dose iodine, which can aggravate autoimmune thyroid disease.
  • Stop biotin before thyroid blood tests; it can distort the results.
  • A gluten-free diet is not indicated without celiac disease or positive blood tests.

Measure: TSH, free T4, symptoms and levothyroxine need. Not TPO antibodies alone.

Multiple sclerosis, very early
  • High-dose vitamin D, physician-directed (Promising, very early MS only). In untreated patients with a first episode or very early MS, disease activity occurred in 60.3% on 100,000 IU every 2 weeks against 74.1% on placebo over 2 years, and the time to new activity was 432 days against 224 (D-Lay MS). The gain was mainly fewer new MRI lesions; the relapse rate itself did not differ.
  • This is not an established protocol for MS in general. Earlier trials adding vitamin D to standard MS drugs were negative, and this dose needs calcium and vitamin D levels monitored.

Measure: relapses, MRI activity and disability progression.

Sjogren's; scleroderma and Raynaud's
  • Sjogren's. I did not find a positive, replicated Western trial of any supplement for the systemic disease. The one agent with repeated controlled data is a Chinese-medicine extract, total glucosides of paeony (white peony root): nine trials of 770 patients showed better saliva and tear flow and lower inflammatory markers, mostly as an add-on, with diarrhea the common side effect (meta-analysis). All the trials are Chinese, and U.S. peony supplements are not that standardized extract, so I don't link one.
  • Sjogren's symptom care. Frequent water, a humidifier, and sugar-free xylitol gum or lozenges to stimulate saliva and protect teeth (xylitol gum on Amazon).
  • Scleroderma. No non-prescription agent has been shown to slow skin or lung fibrosis. For gut symptoms, multi-strain probiotics improved reflux in a 40-patient trial, a 73-patient trial found no benefit, and a 2024 review pooled a reduction in reflux and bloating (Preliminary). Exercise is supported by the European rheumatology recommendations.
  • Raynaud's. Keeping the whole body warm, avoiding cold, and not smoking come first.

Measure in scleroderma: lung function, relevant imaging, and vascular and gut complications.

Sirolimus, and the rest of
what needs a physician

These are on the page because they are non-patented and have a real signal. They are not do-it-yourself items, so none has a purchase link.

Sirolimus (rapamycin)

Sirolimus is the one prescription drug in this guide. It is a natural product of a soil bacterium, Streptomyces hygroscopicus, and it is off patent and available as a generic. Its record is better than its transplant-era reputation suggests, and it is still a drug with side effects of its own.

What the trials showed
  • Lupus, hard to control (Preliminary: no control group). Forty patients took it for 12 months on top of prednisone. The average activity score (SLEDAI) fell from 10.2 to 4.8, the daily prednisone dose fell from 23.7 mg to 7.2 mg, and 16 of the 29 who completed the year improved. Eleven stopped: two for intolerance and nine for not keeping up with the protocol (Lancet 2018).
  • Rheumatoid arthritis (Promising, low certainty). Sixty-two patients were randomized, open-label, for 24 weeks, adding 0.5 mg on alternate days to conventional therapy. DAS28, ESR and joint counts fell, and other immunosuppressants could be reduced. One patient stopped for intolerance (trial).
  • Sjogren's, scleroderma, psoriasis, inflammatory bowel disease. Small pilots and case series only.
How safe it is, checked against the trials
  • Taken alone, serious harm was no more common than on placebo. That held for 12 months at transplant-range blood levels in 89 patients (MILES), and for 48 weeks of weekly low-dose rapamycin in healthy adults (PEARL). Much of the drug's frightening reputation comes from transplant medicine, where it is combined with other immunosuppressants.
  • It is not free of side effects. In MILES, side effects overall were more common on sirolimus. In the lupus trial, HDL cholesterol, neutrophils and hemoglobin fell modestly. Mouth sores, higher lipids, slower wound healing and, rarely, lung inflammation are known effects of this drug class.
  • Blood sugar depends on the schedule. In animals, daily dosing produces glucose intolerance and intermittent dosing largely avoids it (Aging Cell 2016). So the concern is real with daily dosing and weak with intermittent dosing.
Two caveats I won't leave out
  • Both autoimmune trials added sirolimus to prednisone or other immunosuppressants. That is the combination setting where its risks are highest, and it is the position most people reading this are in.
  • The lupus regimen was daily dosing adjusted to a blood level of 6 to 15 ng/mL, not the weekly low-dose schedule that has the cleanest safety record. No autoimmune trial has tested the weekly schedule.

In practice it means a prescription, baseline and follow-up lipids, blood count and glucose or A1c, drug levels when dosing daily, holding it around surgery, avoiding it in pregnancy, and checking interactions: grapefruit, azole antifungals and macrolide antibiotics all raise its level. Compounded rapamycin reached about one-third the blood level of the commercial tablet in PEARL, so the two are not interchangeable. If you want to know whether it fits your situation, that is a conversation for a visit, with your rheumatologist in the loop.

DHEA, for lupus

Across seven randomized trials of 842 patients, most at 200 mg a day, DHEA did not clearly lower disease activity in mild-to-moderate lupus. Patient-rated well-being improved by about 11.5 points on a 100-point scale, and acne was about twice as likely (Cochrane review). (Preliminary: well-being, not disease activity) It is a hormone: avoid it with hormone-sensitive cancers, expect monitoring, and note that long-term safety has not been studied. Sold over the counter, and still one I'd only use with a physician.

Wormwood, for Crohn's disease

In a German trial of 40 patients on prednisone, a wormwood blend (500 mg three times a day for 10 weeks) brought near-complete remission in 65% at 8 weeks against none on placebo, with steroids tapered. A second trial of 20 patients found remission in 80% against 20% (review). (Promising, low certainty) Its thujone content limits dose and duration, standardized products are scarce, and it should be avoided in pregnancy and seizure disorders. Physician-guided only.

High-dose vitamin D, and supervised fasting

Both are covered above: the early-MS vitamin D regimen and the 7-to-10-day fast followed by a vegetarian diet in RA. Each was run under medical supervision in its trials, and that is how I'd run them.

IV therapies: not yet studied enough

My office gives IV therapy, so you should hear this from me. For autoimmune disease specifically, the human evidence is very thin. The single published series of IV vitamin C is 11 rheumatoid arthritis patients at one clinic with no control group: CRP fell in 9 of them, by 44% on average, and joint counts were not measured (case series). I found no autoimmune trials of IV glutathione or NAD+. The better-supported way to raise glutathione is oral N-acetylcysteine.

That is a statement about evidence, not a verdict that they cannot help. But an infusion carries a cost and procedural risks that a capsule does not, high-dose vitamin C needs a G6PD screen first, and I would not put any of them ahead of the items above. IV iron and B12 injections are different: those are standard care for documented deficiency in inflammatory bowel disease.

Herbs that can work
against you

An overactive immune system is the wrong place for an “immune booster.” Some of these have clinical reports of flares; others are flagged only on laboratory evidence. I have kept the two groups separate because they are not equal in risk.

Linked to onset or flares in people
  • Spirulina, chlorella, blue-green algae, echinacea and alfalfa. Linked to onset or flares of dermatomyositis, lupus and pemphigus (review; case series). Spirulina use was 3.76 times more common in dermatomyositis patients than in controls.
Effective, and excluded on safety
  • Thunder god vine (Tripterygium). It matched methotrexate in a 207-patient RA trial (TRIFRA). But menstrual irregularity occurred in 72.7% of premenopausal women taking it with methotrexate (cohort), and reproductive toxicity is its recognized limit.
  • Oral indigo naturalis (Qing Dai). Effective in an 86-patient ulcerative colitis trial, which was stopped after a report of pulmonary arterial hypertension; the authors advised against its use (Gastroenterology 2018; case report). Topical use for psoriasis is unaffected.
Flagged on laboratory evidence of immune stimulation
  • Astragalus, ginseng, reishi, licorice, green tea extract and garlic supplements are named among the herbs with the strongest immune-activating evidence (Lupus Foundation summary). This is laboratory evidence. It does not show that they cause flares in people, and I would not treat them as equal to the first group. With active autoimmune disease I'd still leave them out unless there is a specific reason.
  • Ashwagandha is on that same list, and LiverTox rates it a probable cause of clinically apparent liver injury (case review). I recommend it elsewhere on this site for other purposes; with autoimmune disease, or alongside liver-stressing drugs, I leave it out.
  • Giloy (guduchi, Tinospora cordifolia). Documented liver toxicity (2024 review), and also on the immune-stimulating list.
Other things to leave alone
  • St. John's wort. It lowers blood levels of cyclosporine, tacrolimus and other drugs these patients take, and it increases sun sensitivity.
  • Kelp and iodine megadoses, with thyroid autoimmunity.
  • Unsupervised extended fasting, or a long-term ketogenic diet. The trials were short and supervised.

What success
looks like

Feeling better is worth having, but it can happen while inflammation or organ damage continues. Change one thing at a time, give it the duration the trial used, and judge it by the measure for your condition. If it has not moved, stop it. The goal is the shortest list that works, not the longest.

Condition Measures to follow
Rheumatoid arthritis Joint examination, DAS28 or CDAI, function, X-ray progression where appropriate
Lupus Activity score, urinalysis and urine protein, kidney function, complement, anti-dsDNA where relevant
Ulcerative colitis and Crohn's Symptoms plus fecal calprotectin and CRP, and endoscopy when indicated
Hashimoto's TSH, free T4, symptoms and levothyroxine need, not TPO antibodies alone
Psoriasis PASI, body surface area, global assessment, quality of life
Multiple sclerosis Relapses, MRI activity, disability progression
Scleroderma Lung function, relevant imaging, vascular and gut complications

This matters most where a supplement trial measured only antibodies, cytokines or other lab markers.

Autoimmune disease — FAQs

Can diet or supplements replace my autoimmune medication?

No trial on this page tested that. Every study added diet, a supplement or a lifestyle change to standard treatment. Uncontrolled autoimmune disease causes permanent damage, so these are additions to discuss with your prescriber, not replacements.

What is the best-supported supplement for rheumatoid arthritis?

Omega-3 at 2.7 g or more of EPA plus DHA a day for at least 3 months. Meta-analyses show a consistent but modest reduction in joint pain, morning stiffness and NSAID use. It has not been shown to slow joint damage, and the American College of Rheumatology does not endorse it.

Does curcumin help ulcerative colitis, and is it safe for the liver?

Added to mesalamine, curcumin raised the odds of clinical remission about fivefold across six trials of 349 patients. Rare but serious liver injury has been reported with turmeric supplements, often with black-pepper-enhanced products, so use a product without piperine, stop at dark urine, jaundice or itching, and have liver enzymes checked.

Does vitamin D prevent autoimmune disease?

The first report from the VITAL trial found 22% fewer new autoimmune diagnoses on 2,000 IU a day, but with longer follow-up the difference disappeared. Correcting a low vitamin D level is still sensible; taking it specifically to prevent autoimmune disease is no longer a secure finding.

Do probiotics help Crohn's disease or ulcerative colitis?

They differ. The original 8-strain formulation, sold in the United States as Visbiome, raised remission in ulcerative colitis from about 25% to 44% as an add-on. In Crohn's disease, pooled trials show no effect.

Which supplements should people with autoimmune disease avoid?

Spirulina, chlorella, echinacea and alfalfa have clinical reports of triggering flares. Thunder god vine and oral indigo naturalis work but are excluded on safety. Several other “immune-boosting” herbs are flagged on laboratory evidence only.

What is sirolimus, and why is it in a guide about natural approaches?

Sirolimus, also called rapamycin, is a generic prescription drug produced by a soil bacterium. Small trials in lupus and rheumatoid arthritis showed lower disease activity and steroid doses. It needs a prescription and monitoring, so it appears here as a physician-guided option with no purchase link.

Want this matched to your diagnosis and your medication list?

The right additions depend on which condition you have, how active it is, and what you already take. Bring your medication list and recent labs to a visit and we'll choose the one or two changes worth making, decide how to measure them, and keep your specialist informed.

Request an Appointment →

The studies behind
this guide

Most sources were checked at abstract level. Where the best available source was a trial announcement or a summary rather than the full paper, the label says so.

  1. MEDIPSO Mediterranean diet trial in psoriasis, JAMA Dermatol 2025. View source →
  2. Mediterranean diet and rheumatoid arthritis risk, UK Biobank cohort 2025. View source →
  3. Plants for Joints randomized trial, Rheumatology 2023. View source →
  4. Plants for Joints, 2-year follow-up. View source →
  5. National Psoriasis Foundation medical board dietary recommendations, JAMA Dermatol 2018. View source →
  6. Crohn's disease exclusion diet in adults, Lancet Gastroenterol Hepatol 2022. View source →
  7. Crohn's disease exclusion diet vs Mediterranean diet, 2025 trial. View source →
  8. Time-restricted eating in Crohn's disease, 2026 trial announcement. View source →
  9. Time-restricted eating in Crohn's disease, trial report with inflammatory markers. View source →
  10. Fasting followed by vegetarian diet in rheumatoid arthritis, systematic review 2001. View source →
  11. Fasting in rheumatic disease, umbrella review 2024. View source →
  12. 5:2 fasting in psoriasis, MANGO study. View source →
  13. Ketogenic vs Mediterranean diet in psoriatic disease, trial report. View source →
  14. EULAR 2021 lifestyle recommendations for rheumatic and musculoskeletal diseases. View source →
  15. American College of Rheumatology 2022 integrative guideline for RA, summary. View source →
  16. Sleep duration and lupus risk, Nurses' Health Studies. View source →
  17. Complementary and alternative therapies for psoriasis, JAMA Dermatol 2018. View source →
  18. Omega-3 for inflammatory joint pain, meta-analysis of 17 trials, Pain 2007. View source →
  19. Omega-3 in inflammatory rheumatic disease, 30-trial update 2022. View source →
  20. Diet and supplements in lupus, systematic review 2022. View source →
  21. EPIC trials of omega-3 in Crohn's disease, JAMA 2008. View source →
  22. VITAL two-year post-trial follow-up, Arthritis Rheumatol 2024. View source →
  23. Marine omega-3 supplements and atrial fibrillation, meta-analysis, Circulation 2021. View source →
  24. Curcumin in ulcerative colitis, meta-analysis 2020. View source →
  25. Herbal and plant therapy in inflammatory bowel disease, Ann Gastroenterol 2015. View source →
  26. Curcumin in rheumatoid arthritis, meta-analysis 2023. View source →
  27. Turmeric-associated liver injury, U.S. Drug-Induced Liver Injury Network series 2023. View source →
  28. Eight-strain probiotic in ulcerative colitis, meta-analysis 2014. View source →
  29. Court ruling on VSL#3 and the original De Simone formulation. View source →
  30. American Gastroenterological Association guideline, no recommendation on probiotics in ulcerative colitis. View source →
  31. Probiotics in inflammatory bowel disease including E. coli Nissle 1917, meta-analysis. View source →
  32. Probiotics in Crohn's disease, meta-analysis. View source →
  33. Complementary treatments for lupus, review 2013. View source →
  34. VITAL: vitamin D, omega-3 and new autoimmune disease, BMJ 2022. View source →
  35. Vitamin D3 in Crohn's disease, randomized trial 2010. View source →
  36. Supplements in Hashimoto's thyroiditis, meta-analysis 2024. View source →
  37. Selenium in Hashimoto's thyroiditis, meta-analysis of 35 trials, Thyroid 2024. View source →
  38. Selenium fact sheet, NIH Office of Dietary Supplements. View source →
  39. Selenium tolerable upper intake level, EFSA 2023. View source →
  40. D-Lay MS high-dose vitamin D trial, summary. View source →
  41. Total glucosides of paeony in Sjogren's syndrome, meta-analysis 2019. View source →
  42. Probiotics in systemic sclerosis, randomized trial. View source →
  43. Probiotics in systemic sclerosis, negative 73-patient trial. View source →
  44. Probiotics in systemic sclerosis, systematic review 2024. View source →
  45. Sirolimus in active lupus, Lancet 2018. View source →
  46. Low-dose sirolimus in rheumatoid arthritis, 2019. View source →
  47. MILES trial of sirolimus alone, NEJM 2011. View source →
  48. PEARL trial of weekly low-dose rapamycin, Aging 2025. View source →
  49. Intermittent rapamycin and glucose tolerance, Aging Cell 2016. View source →
  50. DHEA for systemic lupus erythematosus, Cochrane review. View source →
  51. Intravenous vitamin C in rheumatoid arthritis, case series 2012. View source →
  52. Immunostimulatory herbal supplements and autoimmune skin disease, review. View source →
  53. Herbal supplements and autoimmune flares, original case series. View source →
  54. TRIFRA: thunder god vine vs methotrexate. View source →
  55. Thunder god vine plus methotrexate, cohort. View source →
  56. Oral indigo naturalis in ulcerative colitis, Gastroenterology 2018. View source →
  57. Pulmonary arterial hypertension with oral indigo naturalis, case report. View source →
  58. Lupus Foundation of America summary of 15 immune-activating herbs. View source →
  59. Ashwagandha liver injury case and LiverTox rating. View source →
  60. Hepatotoxicity of Ayurvedic herbs, review 2024. View source →

This guide is general education, not personal medical advice, and it does not create a physician-patient relationship. It describes what published studies found; it is not a claim that any product treats, cures or prevents a disease. Do not stop or change a prescribed medication because of anything on this page, and talk with your own physician before adding a supplement, particularly if you take immunosuppressants, blood thinners or liver-stressing drugs, or are pregnant or breastfeeding. Sirolimus and DHEA are discussed for information only and are used here only under a physician's direction. Disclosure: As an Amazon Associate, Starsiak Osteopathic Clinic earns from qualifying purchases made through the Amazon links on this page, and Dr. Starsiak earns from purchases through the Fullscript dispensary, at no extra cost to you. The price you pay is unchanged. You are free to buy equivalent products anywhere, and the advice on this page is the same either way.